QQ客服 官方微博 反馈留言

	Has-miR-125a and 125b are induced by treatment with cisplatin in nasopharyngeal carcinoma and inhibit apoptosis in a p53-dependent manner by targeting p53 mRNA
	Chen, Jian Jun[1,2]; Liu, Shi Xi[3]; Chen, Mian Zhi[3]; Zhao, Zi Yi[2]
	2015
卷号	12期号:3页码:3569-3574
URL标识	查看原文
WOS记录号	WOS:000359933900049
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4320020
专题	成都中医药大学
作者单位	1.[1]First Peoples Hosp Neijiang, Dept Med, Neijiang 641000, Sichuan, Peoples R China 2.[2]Chengdu Univ Tradit Chinese Med, Cent Lab, Teaching Hosp, Chengdu 610000, Sichuan, Peoples R China 3.[3]Sichuan Univ, West China Hosp, Dept ENT, Chengdu 610041, Sichuan, Peoples R China
推荐引用方式 GB/T 7714	Chen, Jian Jun[1,2],Liu, Shi Xi[3],Chen, Mian Zhi[3],et al. Has-miR-125a and 125b are induced by treatment with cisplatin in nasopharyngeal carcinoma and inhibit apoptosis in a p53-dependent manner by targeting p53 mRNA[J],2015,12(3):3569-3574.
APA	Chen, Jian Jun[1,2],Liu, Shi Xi[3],Chen, Mian Zhi[3],&Zhao, Zi Yi[2].(2015).Has-miR-125a and 125b are induced by treatment with cisplatin in nasopharyngeal carcinoma and inhibit apoptosis in a p53-dependent manner by targeting p53 mRNA.,12(3),3569-3574.
MLA	Chen, Jian Jun[1,2],et al."Has-miR-125a and 125b are induced by treatment with cisplatin in nasopharyngeal carcinoma and inhibit apoptosis in a p53-dependent manner by targeting p53 mRNA".12.3(2015):3569-3574.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。